Back to Results
First PageMeta Content
Pharmacology / Pharmaceuticals policy / Food and Drug Administration / Pharmaceutical industry / Drug safety / Center for Drug Evaluation and Research / Investigational New Drug / Over-the-counter drug / New Drug Application / Medicine / Health / Pharmaceutical sciences


Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year[removed]See the Good Guidance Practices (GGPs) regulation on this Web page or 21 CFR[removed]for details about the Guidance Age
Add to Reading List

Open Document

File Size: 41,02 KB

Share Result on Facebook

Company

Medical Product Manufacturing / Bacterial Pneumonia / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

Internet/Social Media Platforms / Internet/Social Media Advertising / /

MedicalCondition

Treatment Uncomplicated Gonorrhea / HIV / Bacterial Pneumonia / Ventilator-Associated Bacterial Pneumonia / /

Organization

FDA / office of Generic Drugs Survey Methodologies / Critical Path Innovation Meeting Division of Good Clinical Practice Compliance / Submitting HIV Resistance Data Hospital / /

Position

General / /

Product

Acetaminophen / Human Prescription Drug / /

Technology

Pharmacokinetics / Spectroscopy / Study Protocols / Annual Report Comparability Protocols / Process Control / Biotechnology / Drug Development / /

SocialTag